HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination of skin-directed therapy and oral etoposide for smoldering adult T-cell leukemia/lymphoma with skin involvement.

Abstract
Approximately 50% of patients with adult T-cell leukemia/lymphoma (ATLL) have skin involvement, and the smoldering, skin lesion-bearing cases are often treated with various skin-directed therapies, such as phototherapy and radiation therapy. Daily oral administration of etoposide plus prednisolone (EP) is also used for smoldering-type ATLL. However, it remains unclear whether these therapies improve patients' survival. We retrospectively analyzed the prognosis of patients with smoldering, skin lesion-bearing ATLL (n = 62), who were treated, as first therapy, with one skin-directed therapy (n = 29), oral EP alone (n = 14) or a combination of skin-directed therapy and oral EP (n = 19). Multivariate analysis revealed that the hazard ratios (HRs) for the overall survival (OS) and progression-free survival (PFS) with the combination therapy were significantly lower than those with the skin-directed therapy (HR 0.1, p = 0.001; HR 0.2, p = 0.002, respectively). These results suggest that the combination of skin-directed therapy and oral EP improves the clinical outcome of patients with smoldering, skin lesion-bearing ATLL.
AuthorsYu Sawada, Takatoshi Shimauchi, Takashi Yamaguchi, Risa Okura, Kayo Hama-Yamamoto, Haruna Fueki-Yoshioka, Shun Ohmori, Shigenori Yamada, Mayuko Yoshizawa, Kana Hiromasa, Makiko Tajiri, Rieko Kabashima-Kubo, Manabu Yoshioka, Kazunari Sugita, Ryutaro Yoshiki, Ryosuke Hino, Miwa Kobayashi, Kunio Izu, Motonobu Nakamura, Yoshiki Tokura
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 54 Issue 3 Pg. 520-7 (Mar 2013) ISSN: 1029-2403 [Electronic] United States
PMID22830614 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Etoposide
  • Prednisolone
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, adverse effects, therapeutic use)
  • Combined Modality Therapy
  • Drug Administration Schedule
  • Etoposide (administration & dosage, adverse effects)
  • Fatigue (etiology)
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Leukemia-Lymphoma, Adult T-Cell (pathology, therapy)
  • Leukopenia (etiology)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Outcome Assessment, Health Care (statistics & numerical data)
  • Prednisolone (administration & dosage, adverse effects)
  • Proportional Hazards Models
  • Retrospective Studies
  • Skin (pathology, radiation effects)
  • Ultraviolet Therapy (adverse effects, methods)
  • Vomiting (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: